Abstract
Screening mammography is generally recommended for women in their 50s and 60s and may also be appropriate for many women in their 40s and 70s. Federal regulation of mammography facilities in the 1990s, prompted by growing use and increased insurance coverage of screening, raised concerns about women’s access to mammography. Since that time, a number of investigators have studied the relationship between geographic access to mammography and the use and outcomes of screening. A review of this literature finds some association between geographic access and use of screening mammography. There is less evidence for an association between geographic access to mammography and breast cancer stage at diagnosis. Despite methodologic challenges to studying these relationships and interpreting findings, results of such studies can help identify areas where geographic access to mammography can be improved. Targeted efforts to enhance geographic access to mammography may increase screening uptake in women for whom it is recommended and reduce disparities in screening use and outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971;215(11):1777–85.
Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69(2):349–55.
Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the health insurance plan project and its sequelae, 1963–1986. Baltimore: Johns Hopkins University Press; 1988.
Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977;39(suppl 6):2772–82.
Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988;297(6654):943–8.
Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Erikson O, et al. The gothenburg breast cancer screening trial: preliminary results on breast cancer mortality for women aged 39–49. J Natl Cancer Inst Monogr. 1997;(22):53–5.
Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Followup after 11 years—update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat. 1997;45(3):263–70.
Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forrest P, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990;335(8684):241–6.
Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health. 1989;43(2):107–14.
Begg CB. The mammography controversy. Oncologist. 2003;7:174–6.
Duffy SW. Interpretation of the breast screening trials: a commentary on the recent paper by Gotzsche and Olsen. Breast. 2001;10(3):209–12.
Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol. 2004;33(1):43–55.
Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355(9198):129–34.
Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340–2.
Olsen O, Gotzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev. (2001, 4).: CD001877
Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, et al. European code against cancer and scientific justification: third version (2003). Ann Oncol. 2003;14(7):973–1005.
Fletcher SW, Black WC, Harris R, Rimer BK, Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst. 1993;85(20):1644–56.
Screening recommendations of the forum panel. J Gerontol. 1992; 47 Speec No: 5.
Dodd GD. American cancer society guidelines from the past to the present. Cancer. 1993;72:1429–32.
Perry S. Recommendations of the consensus development panel on breast cancer screening. Cancer Res. 1978;38(2):476–7.
U.S. Preventive Services Task Force. Guide to clinical services. Baltimore: Williams and Wilkins; 1996.
Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 2016;164(4):244–55.
Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738–47.
Davis WW, Parsons VL, Xie D, Schenker N, Town M, Raghunathan TE, et al. State-based estimates of mammography screening rates based on information from two health surveys. Public Health Rep. 2010;125(4):567–78.
Gonzales FA, Willis GB, Breen N, Yan T, Cronin KA, Taplin SH, et al. An exploration of changes in the measurement of mammography in the National Health Interview Survey. Cancer Epidemiol Biomarker Prev. 2017;26(11):1611–8.
Hiatt RA, Klabunde C, Breen N, Swan J, Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst. 2002;94(24):1837–46.
Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, Tangka FK, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer. 2010;116(20):4872–81.
U.S. Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151(10):716–26.
Siu AL, Force USPST. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279–96.
American College of Obstetricians and Gynecologists. Breast cancer risk assessment and screening in average-risk women. ACOG Practice Bulletin. 2017(179).
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society. J Amer Med Assoc. 2015;314(15):1599–614.
Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, et al. Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns. Am J Manag Care. 2017;23(1):35–40.
Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, et al. The Swedish two-county trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38(4):625–51.
Jonsson H, Tornberg S, Nystrom L, Lenner P. Service screening with mammography of women aged 70–74 years in Sweden: effects on breast cancer mortality. Cancer Detect Prev. 2003;27:360–9.
Lenner P, Jonsson H. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen. 1997;4(1):6–9.
van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65. Int J Cancer. 1997;70(2):164–8.
McCarthy EP, Burns RB, Freunds KM, Ash AS, Shwartz M, Marwill SL, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000;48(10):1226–33.
Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women? Am J Med. 2000;108:112–9.
Solin LJ, Schultz DJ, Legoretta AP, Goodman RL. Downstaging of breast carcinomas in older women associated with mammographic screening. Breast J. 1999;5(2):94–100.
Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999;282(22):2156–63.
U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137(5 Part 1):344–6.
Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, et al. American cancer society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 1997;47(3):150–3.
Sabogal F, Merrill SS, Packel L. Mammography rescreening among older California women. Health Care Financ Rev. 2001;22(4):63–75.
Blanchard K, Colbert JA, Puri D, Weissman J, Moy B, Kopans DB, et al. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer. 2004;101(3):495–507.
Blustein J. Medicare coverage, supplemental insurance, and the use of mammography by older women. New Engl J Med. 1995;332(17):1138–43.
Burns RB, McCarthy EP, Freund KM, Marwill SL, Shwartz M, Ash A, et al. Black women receive less mammography even with similar use of primary care. Ann Intern Med. 1996;125(3):173–82.
Gilliland FD, Rosenberg RD, Hunt WC, Stauber P, Key CR. Patterns of mammography use among Hispanic, American Indian, and non-hispanic white women in New Mexico, 1994–1997. Am J Epidemiol. 2000;152(5):432–7.
Lee JR, Vogel VG. Who uses screening mammography regularly? Cancer Epidemiol Biomarker Prev. 1995;4(8):901–6.
McCarthy EP, Burns RB, Coughlin SS, Freund KM, Rice J, Marwill SL, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128(9):729–36.
Preston JA, Scinto JD, Ni W, Wang Y, Galusha D, Schulz AF, et al. Mammography underutilization among older women in Connecticut. J Am Geriatr Soc. 1997;45(11):1310–4.
Rahman SM, Dignan MB, Shelton BJ. Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older. Ethn Dis. 2003;13(4):477–84.
Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528–40.
Facione NC. Breast cancer screening in relation to access to health services. Oncol Nurs Forum. 1999;26(4):689–96.
Kruse J, Phillips DM. Factors influencing women’s decision to undergo mammography. Obstet Gynecol. 1987;70(5):744–8.
Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women’s adherence to mammography screening guidelines. Health Serv Res. 1998;33(1):29–53.
Potvin L, Camirand J, Beland F. Patterns of health services utilization and mammography use among women aged 50–59 years in the Quebec Medicare system. Med Care. 1995;33(5):515–30.
Rakowski W, Breen N, Meissner H, Rimer BK, Vernon SW, Clark MA, et al. Prevalence and correlates of repeat mammography among women aged 55–79 in the Year 2000 National Health Interview Survey. Prev Med. 2004;39(1):1–10.
Schootman M, Jeffe DB, Reschke AH, Aft RL. Disparities related to socioeconomic status and access to medical care remain in the United States among women who never had a mammogram. Cancer Causes Control. 2003;14(5):419–25.
Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst. 2004;96(20):1518–27.
Urban N, Anderson GL, Peacock S. Mammography screening: how important is cost as a barrier to use? Am J Public Health. 1994;84(1):50–5.
Zapka JG, Hosmer D, Costanza ME, Harris DR, Stoddard A. Changes in mammography use: economic, need, and service factors. Am J Public Health. 1992;82(10):1345–51.
Bryant H, Mah Z. Breast cancer screening attitudes and behaviors of rural and urban women. Prev Med. 1992;21(4):405–18.
Adams EK, Florence CS, Thorpe KE, Becker ER, Joski PJ. Preventive care: female cancer screening, 1996–2000. Am J Prev Med. 2003;25(4):301–7.
Rao RS, Graubard BI, Breen N, Gastwirth JL. Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care. 2004;42(8):789–800.
Taylor VM, Taplin SH, Urban N, White E, Peacock S. Repeat mammography use among women ages 50–75. Cancer Epidemiol Biomarker Prev. 1995;4(4):409–13.
Kelaher M, Stellman JM. The impact of medicare funding on the use of mammography among older women: implications for improving access to screening. Prev Med. 2000;31(6):658–64.
Makuc DM, Freid VM, Parsons PE. Health insurance and cancer screening among women. Hyattsville: National Center for Health Statistics; 1994. Contract No.: 254
Haggstrom DA, Phillips KA, Liang SY, Haas JS, Tye S, Kerlikowske K. Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control. 2004;15(9):883–92.
Phillips KA, Haas JS, Liang SY, Baker LC, Tye S, Kerlikowske K, et al. Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res. 2004;39(1):153–78.
Barr JK, Reisine S, Wang Y, Holmboe EF, Cohen KL, Van Hoof TJ, et al. Factors influencing mammography use among women in medicare managed care. Health Care Financ Rev. 2001;22(4):49–61.
Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME. Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer. 2002;95(2):219–27.
Finney Rutten LJ, Iannotti RJ. Health beliefs, salience of breast cancer family history, and involvement with breast cancer issues: adherence to annual mammography screening recommendations. Cancer Detect Prev. 2003;27(5):353–9.
Finney Rutten LJ, Nelson DE, Meissner HI. Examination of population-wide trends in barriers to cancer screening from a diffusion of innovation perspective (1987–2000). Prev Med. 2004;38(3):258–68.
Halabi S, Skinner CS, Samsa GP, Strigo TS, Crawford YS, Rimer BK. Factors associated with repeat mammography screening. J Fam Pract. 2000;49(12):1104–12.
Harper AP. Mammography utilization in the poor and medically underserved. Cancer. 1993;72(4 Suppl):1478–82.
Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19(3):279–90.
Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 1993;85(13):1074–80.
Rimer BK, Trock B, Engstrom PF, Lerman C, King E. Why do some women get regular mammograms? Am J Prev Med. 1991;7(2):69–74.
Stein JA, Fox SA, Murata PJ. The influence of ethnicity, socioeconomic status, and psychological barriers on use of mammography. J Health Soc Behav. 1991;32(2):101–13.
Stein JA, Fox SA, Murata PJ, Morisky DE. Mammography usage and the health belief model. Health Educ Q. 1992;19(4):447–62.
Stomper PC, Gelman RS, Meyer JE, Gross GS. New England mammography survey: public misconceptions of breast cancer incidence. Breast Dis. 1990;3:1–7.
White E, Urban N, Taylor V. Mammography utilization, public health impact, and cost-effectiveness in the United States. Annu Rev Public Health. 1993;14:605–33.
Calvocoressi L, Kasl SV, Lee CH, Stolar M, Claus EB, Jones BA. A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and white women ages 40–79 years. Cancer Epidemiol Biomarker Prev. 2004;13(12):2096–105.
Glanz K, Resch N, Lerman C, Rimer BK. Black-white differences in factors influencing mammography use among employed female health maintenance organization members. Ethn Health. 1996;1(3):207–20.
Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991;81(4):501–4.
Messina CR, Lane DS, Glanz K, West DS, Taylor V, Frishman W, et al. Relationship of social support and social burden to repeated breast cancer screening in the women’s health initiative. Health Psychol. 2004;23(6):582–94.
Vernon SW, Laville EA, Jackson GL. Participation in breast screening programs: a review. Soc Sci Med. 1990;30(10):1107–18.
Lane DS, Caplan LS, Grimson R. Trends in mammography use and their relation to physician and other factors. Cancer Detect Prev. 1996;20(4):332–41.
Zapka JG, Stoddard A, Maul L, Costanza ME. Interval adherence to mammography screening guidelines. Med Care. 1991;29(8):697–707.
Fox SA, Murata PJ, Stein JA. The impact of physician compliance on screening mammography for older women. Arch Intern Med. 1991;151(1):50–6.
Hawley ST, Earp JA, O’Malley M, Ricketts TC. The role of physician recommendation in women’s mammography use: is it a 2-stage process? Med Care. 2000;38(4):392–403.
Howe HL. Repeat mammography among women over 50 years of age. Am J Prev Med. 1992;8(3):182–5.
Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women. Does the sex of the physician matter? N Engl J Med. 1993;329(7):478–82.
Roetzheim R, Fox SA, Leake B, Houn F. The influence of risk factors on breast carcinoma screening of medicare-insured older women. National Cancer Institute Breast Cancer Screening Consortium. Cancer. 1996;78(12):2526–34.
Stoddard AM, Rimer BK, Lane D, Fox SA, Lipkus I, Luckmann R, et al. Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium. Prev Med. 1998;27(3):478–87.
Taplin SH, Urban N, Taylor VM, Savarino J. Conflicting national recommendations and the use of screening mammography: does the physician’s recommendation matter? J Am Board Fam Pract. 1997;10(2):88–95.
Finison KS, Wellins CA, Wennberg DE, Lucas FL. Screening mammography rates by specialty of the usual care physician. Eff Clin Pract. 1999;2(3):120–5.
Burns RB, Freund KM, Ash A, Shwartz M, Antab L, Hall R. Who gets repeat screening mammography: the role of the physician. J Gen Intern Med. 1995;10(9):520–2.
Lurie N, Margolis KL, McGovern PG, Mink PJ, Slater JS. Why do patients of female physicians have higher rates of breast and cervical cancer screening? J Gen Intern Med. 1997;12(1):34–43.
Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res. 2004;39(6 Pt 1):1751–72.
Decker SL, Hempstead K. HMO penetration and quality of care: the case of breast cancer. J Health Care Financ. 1999;26(1):18–32.
Ferrante JM, Gonzalez EC, Pal N, Roetzheim RG. Effects of physician supply on early detection of breast cancer. J Am Board Fam Pract. 2000;13(6):408–14.
Mammography Quality Standards Act, Pub. L. No. 102–539, 106 Stat. 3547(1992).
Mammography Quality Standards Reauthorization Act of 1998, Pub. L. No. PL 105–248(1998).
Mammography Quality Standards Reauthorization Act of 2004, Pub. L. No. PL 108–365(2004).
U.S. General Accounting Office. Mammography services: initial impact of new federal law has been positive. Washington, DC: U.S. General Accounting Office; 1995. Report No.: GAO/HEHS-96-17
U.S. General Accounting Officee. FDA’s mammography inspections: while some problems need attention, facility compliance is growing. Washington, DC: U.S. General Accounting Office; 1997. Report No.: GAO/HEHS-97-25
U.S. General Accounting Office. Mammography services: impact of federal legislation on quality, access and health outcomes. Washington, DC: U.S. General Accounting Office; 1997. Report No.: GAO/HEHS-98-11
U.S. General Accounting Office. Mammography quality standards act: X-ray quality improved, access unaffected, but impact on health outcomes unknown. Washington, DC: U.S. General Accounting Office; 1998. Report No.: GAO/T-HEHS-98-164
U.S. Government Accountability Office. Mammography: capacity generally exists to deliver services. Washington, DC: U.S. General Accounting Office; 2002. Report No.: GAO-02-532
Korn JE, Casey-Paal A, Lazovich D, Ball J, Slater JS. Impact of the mammography quality standards act on access in Minnesota. Public Health Rep. 1997;112(2):142–5.
Fischer R, Houn F, Van De Griek A, Tucker SA, Meyers D, Murphy M, et al. The impact of the mammography quality standards act on the availability of mammography facilities. Prev Med. 1998;27:697–701.
Khan-Gates JA, Ersek JL, Eberth JM, Adams SA, Pruitt SL. Geographic access to mammography and its relationship to breast cancer screening and stage at diagnosis: a systematic review. Womens Health Issues. 2015;25(5):482–93.
Engelman KK, Hawley DB, Gazaway R, Mosier MC, Ahluwalia JS, Ellerbeck EF. Impact of geographic barriers on the utilization of mammograms by older rural women. J Am Geriatr Soc. 2002;50(1):62–8.
Meersman SC, Breen N, Pickle LW, Meissner HI, Simon P. Access to mammography screening in a large urban population: a multi-level analysis. Cancer Causes Control. 2009;20(8):1469–82.
Jackson MC, Davis WW, Waldron W, McNeel TS, Pfeiffer R, Breen N. Impact of geography on mammography use in California. Cancer Causes Control. 2009;20(8):1339–53.
Mobley LR, Kuo TM, Clayton LJ, Evans WD. Mammography facilities are accessible, so why is utilization so low? Cancer Causes Control. 2009;20(6):1017–28.
Rahman S, Price JH, Dignan M, Rahman S, Lindquist PS, Jordan TR. Access to mammography facilities and detection of breast cancer by screening mammography: a GIS approach. Int J Cancer Prev. 2009;2(6):403–13.
Luo W, Wang F. Measures of spatial accessibility to health care in a GIS environment: synthesis and case study in the Chicago region. Environ Plann B Plann Des. 2003;30:865–84.
Elting LS, Cooksley CD, Bekele BN, Giordano SH, Shih YC, Lovell KK, et al. Mammography capacity impact on screening rates and breast cancer stage at diagnosis. Am J Prev Med. 2009;37(2):102–8.
Jewett PI, Gangnon RE, Elkin E, Hampton JM, Jacobs EA, Malecki K, et al. Geographic access to mammography facilities and frequency of mammography screening. Ann Epidemiol. 2018;28(2):65–71 e2.
Assessment of the Availability of Mammography Services: Final Report. Lexington: Eastern Research Groupm, Inc. Prepared for the Office of Policy, Planning, and Legislation, Food and Drug Administration; 2001.
Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med. 2008;66(2):260–75.
Elkin EB, Ishill NM, Snow JG, Panageas KS, Bach PB, Liberman L, et al. Geographic access and the use of screening mammography. Med Care. 2010;. in press
Zenk SN, Tarlov E, Sun J. Spatial equity in facilities providing low- or no-fee screening mammography in Chicago neighborhoods. J Urban Health. 2006;83(2):195–210.
Peipins LA, Graham S, Young R, Lewis B, Foster S, Flanagan B, et al. Time and distance barriers to mammography facilities in the Atlanta metropolitan area. J Community Health. 2011;36(4):675–83.
Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, et al. Geographic access to breast imaging for US women. J Am Coll Radiol. 2014;11(9):874–82.
Elkin EB, Atoria CL, Leoce N, Bach PB, Schrag D. Changes in the availability of screening mammography, 2000–2010. Cancer. 2013;119(21):3847–53.
Peipins LA, Miller J, Richards TB, Bobo JK, Liu T, White MC, et al. Characteristics of US counties with no mammography capacity. J Community Health. 2012;37(6):1239–48.
Alford-Teaster J, Lange JM, Hubbard RA, Lee CI, Haas JS, Shi X, et al. Is the closest facility the one actually used? An assessment of travel time estimation based on mammography facilities. Int J Health Geogr. 2016;15:8.
Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, et al. Travel burden to breast MRI and utilization: are risk and sociodemographics related? J Am Coll Radiol. 2016;13(6):611–9.
Elkin EB, Paige Nobles J, Pinheiro LC, Atoria CL, Schrag D. Changes in access to screening mammography, 2008–2011. Cancer Causes Control. 2013;24(5):1057–9.
Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved. 1995;6(3):342–51.
Gumpertz ML, Pickle LW, Miller BA, Bell BS. Geographic patterns of advanced breast cancer in Los Angeles: associations with biological and sociodemographic factors (United States). Cancer Causes Control. 2006;17(3):325–339.
Huang B, Dignan M, Han D, Johnson O. Does distance matter? Distance to mammography facilities and stage at diagnosis of breast cancer in Kentucky. J Rural Health. 2009;25(4):366–71.
Dai D. Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place. 2010;16(5):1038–52.
Onitilo AA, Liang H, Stankowski RV, Engel JM, Broton M, Doi SA, et al. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis. Rural Remote Health. 2014;14(3):2738.
Tarlov E, Zenk SN, Campbell RT, Warnecke RB, Block R. Characteristics of mammography facility locations and stage of breast cancer at diagnosis in Chicago. J Urban Health. 2009;86(2):196–213.
McLafferty S, Wang F. Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois. Cancer. 2009;115(12):2755–64.
Wang F, Guo D, McLafferty S. Constructing geographic areas for cancer data analysis: a case study on late-stage breast cancer risk in illinois. Appl Geogr. 2012;35(1–2):1–11.
Roche LM, Skinner R, Weinstein RB. Use of a geographic information system to identify and characterize areas with high proportions of distant stage breast cancer. J Public Health Manag Pract. 2002;8(2):26–32.
Schroen AT, Lohr ME. Travel distance to mammography and the early detection of breast cancer. Breast J. 2009;15(2):216–7.
Celaya MO, Berke EM, Onega TL, Gui J, Riddle BL, Cherala SS, et al. Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998–2004). Rural Remote Health. 2010;10(2):1361.
Onega T, Cook A, Kirlin B, Shi X, Alford-Teaster J, Tuzzio L, et al. The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat. 2011;129(1):269–75.
Goovaerts P. Visualizing and testing the impact of place on late-stage breast cancer incidence: a non-parametric geostatistical approach. Health Place. 2010;16(2):321–30.
Marchick J, Henson DE. Correlations between access to mammography and breast cancer stage at diagnosis. Cancer. 2005;103(8):1571–80.
Henry KA, Boscoe FP, Johnson CJ, Goldberg DW, Sherman R, Cockburn M. Breast cancer stage at diagnosis: is travel time important? J Community Health. 2011;36(6):933–42.
Mobley LR, Kuo TM, Scott L, Rutherford Y, Bose S. Modeling geospatial patterns of late-stage diagnosis of breast cancer in the US. Int J Environ Res Public Health. 2017;14(5)
Gold RH, Bassett LW, Widoff BE. Highlights from the history of mammography. RadioGraphics. 1990;10:1111–31.
Elkin EB, Atoria CL, editors. Mobile mammography facilities and access to breast cancer screening. Washington, DC: ESRI Health GIS Conference; 2011.
Vyas A, Madhavan S, Kelly K, Metzger A, Schreiman J, Remick S. Do Appalachian women attending a mobile mammography program differ from those visiting a stationary mammography facility? J Community Health. 2013;38(4):698–706.
Stanley E, Lewis MC, Irshad A, Ackerman S, Collins H, Pavic D, et al. Effectiveness of a mobile mammography program. AJR Am J Roentgenol. 2017;209(6):1426–9.
Farria DM, Schmidt ME, Monsees BS, Smith RA, Hildebolt C, Yoffie R, et al. Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey. Cancer. 2005;104(3):491–8.
Baxi SS, Snow JG, Liberman L, Elkin EB. The future of mammography: radiology residents’ experiences, attitudes, and opinions. AJR Am J Roentgenol. 2010;194(6):1680–6.
Sharafinski ME Jr, Nussbaum D, Jha S. Supply/demand in radiology: a historical perspective and comparison to other labor markets. Acad Radiol. 2016;23(2):245–51.
Misono AS, Saini S, Prabhakar AM. Radiology jobs: uncovering hidden and not-so-hidden opportunities from the ACR jobs board. J Am Coll Radiol. 2016;13(4):471–6.
Zahnd WE, McLafferty SL. Contextual effects and cancer outcomes in the United States: a systematic review of characteristics in multilevel analyses. Ann Epidemiol. 2017;27(11):739–48.. e3
Lian M, Struthers J, Schootman M. Comparing GIS-based measures in access to mammography and their validity in predicting neighborhood risk of late-stage breast cancer. PloS one. 2012;7(8):e43000.
Cromley EK, McLafferty S. GIS and public health. New York: Guilford Press; 2002.
Zahnd WE, Fogleman AJ, Jenkins WD. Rural-urban disparities in stage of diagnosis among cancers with preventive opportunities. Am J Prev Med. 2018;54(5):688–98.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Elkin, E.B. (2019). Geographic Influences on Screening Mammography. In: Berrigan, D., Berger, N. (eds) Geospatial Approaches to Energy Balance and Breast Cancer. Energy Balance and Cancer, vol 15. Springer, Cham. https://doi.org/10.1007/978-3-030-18408-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-18408-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18407-0
Online ISBN: 978-3-030-18408-7
eBook Packages: MedicineMedicine (R0)